Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Why I Advocate for Arthritis: A Patient’s Perspective

Rev. Anthony J. Hillelson  |  Issue: August 2013  |  August 1, 2013

I was diagnosed with RA almost 15 years ago, after being misdiagnosed for four years. I am now 61. The delay in receiving an accurate diagnosis caused me to pay a high price in my health due to the lack of immediate, aggressive treatment. My experiences with RA and the enormous challenges of finding the right treatment inspired me to join the ACR’s Advocates for Arthritis, uniting with fellow patients, rheumatologists, and others to educate members of Congress about our diseases and treatments.

I am considered treatment resistant, as none of the biologic drugs have worked for me. The ongoing, fast advancement of my RA has caused considerable damage to my joints and connective tissues, including the ligaments and tendons. I have had to walk with a walker for the past three years because my right foot has turned inward, leaving my balance unpredictable. I have fallen several times in the past few years, broken my left wrist twice, and have had fractures in my spine. Additionally, my hands continue to become more deformed over time. Simple tasks that I once took for granted are now impossible as my disease continues to advance without anything to slow down the process. I live daily with excruciating pain.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

My story is one of millions of stories across America. That is why I consider myself to be fortunate indeed to have been able to take part in the ACR’s Advocates for Arthritis fly-in conference, so that I can share my personal story. We need the help of members of Congress to ensure that greater funding becomes available to researchers for improved treatments for people with rheumatic diseases, and to ensure that patients like me may actually have access to those treatments once they become available, without excessive patient cost-sharing or coinsurance fees.

Awareness is key, and the ACR does an amazing job at bringing knowledge to those lawmakers who can make these life-saving decisions. Bravo, ACR! I have lived, survived, and often thrived with severe RA, moderate lupus, and Sjögren’s syndrome for the past 15 years. This is a very personal journey for me. Joining other ACR advocates, whether I am physically in Washington, D.C., or as a virtual participant, is a great passion of mine. I may never see a cure for these devastating diseases in my lifetime, but I am proud to work together with rheumatologists, health professionals, and other patients to ensure that generations after us can live the cure.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:AC&RAdvocacyArthritisCongressFundingRheumatic Disease

Related Articles

    Why I Advocate for Arthritis: A Rheumatologist’s Perspective

    September 1, 2013

    Chris Morris, MD, on why lobbying Congress is critical to maintain physicians’ ability to provide quality care to rheumatology patients

    A Unified Advocacy Voice for Rheumatology

    June 13, 2021

    One thing that became clear very quickly this past year was that the COVID-19 pandemic would change the way we deliver care to patients. What has not changed amid an evolving healthcare landscape is our driving focus to ensure our patients’ access to rheumatology care and the availability of state-of-the-art treatments. We know you share…

    Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing

    December 20, 2017

    SAN DIEGO—The 2017 ACR/ARHP Annual Meeting, Nov. 3–8, presented opportunities to highlight its 2017 legislative advocacy victories, some of which were resolved just weeks before the conference began, as well as issues that are still outstanding. In the session, Legislative & Regulatory Update 2017, Angus Worthing, MD, chair of the ACR’s Government Advocacy Committee and…

    Rheumatology Patients & Providers Push for Step Therapy, Workforce Changes

    September 20, 2019

    Rheumatology professional and patients visited with 117 legislators and their staffs during the 2019 Advocates for Arthritis event to champion better rheumatology patient care and access.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences